Copyright
©The Author(s) 2022.
World J Clin Cases. Sep 16, 2022; 10(26): 9264-9275
Published online Sep 16, 2022. doi: 10.12998/wjcc.v10.i26.9264
Published online Sep 16, 2022. doi: 10.12998/wjcc.v10.i26.9264
Table 2 Influence of high-risk factors on primary liver cancer stratified by clinical stage of cirrhosis
| Factors | Criterion: Clinical stage of cirrhosis | Statistics | P value | ||
| No cirrhosis | Compensated | Decompensated | |||
| Male (%) | 99 (72.3) | 33 (78.6) | 84 (77.1) | 1.08 | 0.582 |
| Age (yr) | 62.93 ± 11.85 | 61.21 ± 1.58 | 60.93 ± 9.04 | 1.14 | 0.322 |
| History of smoking (%) | 47 (34.3) | 13 (30.2) | 37 (33.9) | 0.26 | 0.880 |
| History of drinking (%) | 50 (36.5) | 11 (26.2) | 39 (35.8) | 1.59 | 0.451 |
| HBsAg (+) (%) | 46 (33.6) | 32 (76.2) a | 76 (69.1) a | 41.27 | < 0.001 |
| HCV-Ag (+) (%) | 9 (6.6) | 2 (4.8) | 6 (5.5) | 0.25 | 0.883 |
| Non-alcoholic fatty liver (%) | 39 (28.5) | 9 (21.4) | 19 (17.3) | 4.38 | 0.112 |
- Citation: Jiao HB, Wang W, Guo MN, Su YL, Pang DQ, Wang BL, Shi J, Wu JH. Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer. World J Clin Cases 2022; 10(26): 9264-9275
- URL: https://www.wjgnet.com/2307-8960/full/v10/i26/9264.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i26.9264